It is significant that the latest Guidelines now include due diligence expectations in the re-framed "Science, Technology and Innovation" chapter relating to the development, financing, sale, licensing, trade and use of technology, including gathering and using data. In its 'Final Report on Minimum Safeguards' the Platform on Sustainable Finance ("PSF") noted that science and technology was not considered relevant in the context of determining alignment with the minimum safeguards under Article 18 of the EU TR. This was on the basis that the due diligence requirements did not extend to this chapter. Given the OECD update, it will be interesting to see whether this development will be built into future guidance (including an updated Due Diligence Guide) and recommendations relating to the EU TR minimum safeguards assessment and, by extension, the SFDR's 'do no significant harm' assessment (see our briefing for further details on the PSF's report and recommendations).
Proportionality and risk-based approaches
The Guidelines have previously qualified due diligence expectations as being those that are "appropriate" to the nature of the entity and the underlying actual or potential adverse impact. This has been updated to align with the Due Diligence Guide to more clearly emphasize risk-based due diligence processes and measures that are both commensurate to the severity and likelihood of the adverse impact and appropriate and proportionate to its context. Consequently, adverse impacts which are severe or likely should be prioritised over those that are less severe or unlikely.
The risk-based approach has been drawn on heavily in the EU Parliament and Council's approach to the draft CS3D's due diligence requirements and is a key element of the double materiality assessment that will precede and inform the reporting of sustainability information by companies under the Corporate Sustainability Reporting Directive (CSRD) (see our previous briefings here and here).
Business relationships
Business relationships are widely defined under the Guidelines and can include entities in the supply chain, which supply products or services that contribute to the enterprise's own operations, products or services, or which receive, license, buy or use products or services from the enterprise. It may also include relationships with investee companies, clients and joint venture parties.
There is a shifted focus away from an MNE's own operations and activities to the operations and activities of its value chains (this is an ongoing trend in UK litigation and EU legislation – see our recent briefings on UK value chain liability and CS3D here).
The Guidelines recognise that by focusing on value chains there is a risk that the responsibility will shift away from the entity causing or contributing to an adverse impact, to an entity less equipped to bear it, at a different point in the supply chain or value chain. Instead of offloading responsibility, the Guidelines recommend that multinational enterprises use their “leverage” to prevent or mitigate impacts in their value chains. The Guidelines define leverage as the ability to "influence or encourage" or effect change in the practices of another entity that is causing an adverse impact or to prevent or mitigate that impact.
While the DD Guidance is applicable to businesses across all sectors, there are some challenges in applying it to, for example, investment activities. As reported in our recent Sustainability Insights briefing, the UNPRI* has developed guidance on Human Rights Due Diligence for Private Markets Investors summarising the requirements of the UNGPs, and their specific application to investors with significant influence or control. As noted in our briefing, the guide makes a clear distinction between the obligations of an investor in a company, including a private equity investor with a control position, and the obligations of the company itself. Generally, an investor will be "linked to" the impacts of its portfolio companies, rather than having a greater level of involvement (although that is an important factual question which should be answered based on the specific circumstances). Investors who are "linked to" adverse impacts should contribute to the "remedy ecosystem", but may not have to provide the remedy themselves. This aligns, again, with the position by the European Parliament for the CS3D.